Wockhardt - Spectra

Name of RM :
HQ: Month :

No of listed Drs met

Stockiest Powercef Floxur-OZ
Date Day Tour Plan Actual area wrkd Name of the TM FW Total Drs converted Brands
met ROB ROB
Core Imp. Dr No of Retail met yes/no
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
10 0
11 0
12 0
13 0
14 0
15 0
16 0
17 0
18 0
19 0
20 0
21 0
22 0
23 0
24 0
25 0
26 0
27 0
28 0
29 0
30 0
31 0
0 0 0 0 0 0 0 0
Dr.Call ave #DIV/0! #DIV/0! 0.00 0

To be updated and mailed every 7TH,14TH,21ST AND 31ST

Wockhardt - Spectra

Name of RM :
HQ: Month:

Joint Work Analysis

Date of Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Total
TM Name HQ Name Grading
Joining Days Drs. Days Drs. Days Drs. Days Drs. Days Drs. Days Drs. Days Drs. Days Drs. Days Drs. Days Drs.
### ###
### ###
### ###
### ###
### ###
### ###
### ###
### ###
### ###
### ###
Total 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ### ###

Note:
Mention details of joint work with each individual separately.
If the field staff has changed due to any reason (resignation, promotion, transfer, etc), insert row and include the new person joined.
Do not delete names of people who left from the HQ.
Wockhardt - Spectra

Name of RM :
HQ:

HQ - Performance Summary
(Enter values in Rs. Lakhs) Secondary Sales (Net) at PTS
Targets Primary Sale Secondary Sales
Head Quarter Ach 2012/13 Total (YTD) Total (YTD) % Ach Total (YTD) % Ach.
Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
0.00 0.00 0.0 0.00 0.0
RM (Mention HQ) 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.0

Market Inventory (Value at PTS) Market Inventory No. of Days

Head Quarter Ach 2012/13
Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0
RM (Mention HQ) 0 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 0 0 0 0 0 0 0 0
Wockhardt - Spectra

Name of RM :
HQ:

Brand Performance-REGION
Month
Brands Sec. Sec. Pri.
(Value) Pri. Sales Pri. Sales Pri. Sales % Growth
Sales Sales Sales
Tgt. Ach. % Ach. (Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0.00 0.00 0 0.00 0 0.00 0
CEFIWOK XL 0.00 0.00 0 0.00 0 0.00 0
CEFIWOK-200 0.00 0.00 0 0.00 0 0.00 0
CEFIWOK OTHERS 0.00 0.00 0 0.00 0 0.00 0
TRAM-PROXYVON CAPS 0.00 0.00 0 0.00 0 0.00 0
TRAM-PROXYVON INJ 0.00 0.00 0 0.00 0 0.00 0
BUTA-PROXYVON CAPS 0.00 0.00 0 0.00 0 0.00 0
BUTA-PROXYVON GEL 0.00 0.00 0 0.00 0 0.00 0
NADIMIX 0.00 0.00 0 0.00 0 0.00 0
B.G.PROT GROUP 0.00 0.00 0 0.00 0 0.00 0
POWERPOD SUSP 0.00 0.00 0 0.00 0 0.00 0
OTHER BRANDS 0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
0.00 0.00 0 0.00 0 0.00 0
Total 0.00 0.00 0 0.00 0.00 0

TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
 0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0

TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0

TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
 0 0 0
Total 0.00 0.00 0 0.00 0.00 0

TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0

TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0

TM
HQ
Month
Brands Sec. Sec. Pri.
Pri. Sales Pri. Sales Pri. Sales % Growth
(Value) Tgt. Ach. % Ach.
Sales Sales Sales
(Pri.)
Ach. % Ach. (SPLY)
CEFIWOK-O 0 0 0
CEFIWOK XL 0 0 0
CEFIWOK-200 0 0 0
CEFIWOK OTHERS 0 0 0
TRAM-PROXYVON CAPS 0 0 0
TRAM-PROXYVON INJ 0 0 0
BUTA-PROXYVON CAPS 0 0 0
BUTA-PROXYVON GEL 0 0 0
NADIMIX 0 0 0
B.G.PROT GROUP 0 0 0
POWERPOD SUSP 0 0 0
OTHER BRANDS 0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
Total 0.00 0.00 0 0.00 0.00 0
 YTD

Sec. % Pri. Pri. Sec. Sec. %

Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0

YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
 0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0

YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0

YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
 0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0

YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0

YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
 YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0

YTD
Sec. % Pri. Pri. Sec. Sec. %
Pri. Sales Pri. Sales
Sales Growth Sales Sales % Sales Sales % Growth
Tgt. (SPLY)
(SPLY) (Sec.) Ach. Ach. Ach. Ach. (Pri.)
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.0 0 0 0
0.00 0.0 0.00 0.00 0 0.00 0 0.00 0
 %
Sec. Sales
Growth
(SPLY)
(Sec.)
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0
0.00 0.0

%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
 0.0
0.0
0.0
0.00 0.0

%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0

%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
 0.0
0.00 0.0

%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0

%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
 %
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0

%
Sec. Sales
Growth
(SPLY)
(Sec.)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.00 0.0
Wockhardt - Spectra

Name of RM :
HQ:

Coverage Analysis

Core Dr. Coverage

No. of
Head Quarter Name of TM : Days Met
Worked Not Met Met Once
Twice

Sub Total 0 0 0 0
 Apr-12
Core Dr. Coverage Important Dr. Coverage

% Core % DML
Met > Met > % Coverage
Total Dr. Not Met Met Once Total
Twice Once Coverage
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0 0.0 0 0 0 0 0.0 0.0
 C
Total No. No. of
Call Chemist
of Dr. No. of POB Name of ME : Days
Avg. Call Avg. Not Met
Calls Chemist Worked
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0 0.0 0 0.0 0 0 0
 May-12
Core Dr. Coverage Important Dr. Coverage

Met Met > % Core Dr. Met >

Met Once Total Not Met Met Once Total
Twice Twice Coverage Once

0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0 0 0 0.0 0 0 0 0
overage
Total No.
% DML Call Chemist
% of Dr. No. of POB
Coverage Avg. Call Avg.
Coverage Calls Chemist
Met
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0 0.0 0 0.0 0
 Jun-12
Core Dr. Coverage
No. of
Name of ME : Days % Core
Met Met >
Worked Not Met Met Once Total Dr.
Twice Twice
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0 0.0
 Jun-12
Important Dr. Coverage
Total No.
% DML Call
Met > % of Dr. No. of
Not Met Met Once Total Coverage Avg.
Once Coverage Calls Chemist
Met
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0 0 0 0.0 0.0 0 0.0 0
 Core Dr. Coverage
No. of
Chemist
POB Name of ME : Days Met Met >
Call Avg. Not Met Met Once
Worked Twice Twice

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0 0.00 0 0 0 0 0
 Jul-12
Coverage Important Dr. Coverage
Total No.
% Core % DML
Met > % of Dr.
Total Dr. Not Met Met Once Total Coverage
Once Coverage Calls
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0 0 0 0.0 0.0 0
 Core Dr. Co
No. of
Call Chemist
No. of POB Name of ME : Days
Avg. Call Avg. Not Met Met Once
Chemist Worked
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0 0.0 0.00 0 0 0
 Aug-12
Core Dr. Coverage Important Dr. Coverage

% Core
Met Met > Met > %
Total Dr. Not Met Met Once Total
Twice Twice Once Coverage
Coverage
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0 0 0.0 0 0 0 0 0.0
 Total No. No. of
% DML Call Chemist
of Dr. No. of POB Name of ME : Days
Coverage Avg. Call Avg.
Calls Chemist Worked
Met
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0 0.0 0 0.0 0 0
 Sep-12
Core Dr. Coverage Important Dr. Coverage

% Core
Met Met > Met >
Not Met Met Once Total Dr. Not Met Met Once
Twice Twice Once
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0.0 0 0 0
rtant Dr. Coverage
Total No.
% DML Call Chemist
% of Dr. No. of POB
Total Coverage Avg. Call Avg.
Coverage Calls Chemist
Met
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0 0.0 0 0.0 0.00
 Oct-12
Core Dr. Coverage
No. of
Name of ME : Days % Core
Met Met >
Worked Not Met Met Once Total Dr.
Twice Twice
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0 0.0
 Oct-12
Important Dr. Coverage
Total No.
% DML Call
Met > % of Dr. No. of
Not Met Met Once Total Coverage Avg.
Once Coverage Calls Chemist
Met
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0.0 0.0 0.0
0 0 0 0 0.0 0.0 0 0.0 0
 Core Dr. Coverage
No. of
Chemist
POB Name of ME : Days Met Met >
Call Avg. Not Met Met Once
Worked Twice Twice

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0 0 0 0 0 0 0
 Nov-12
Coverage Important Dr. Coverage
Total No.
% Core % DML
Met > % of Dr.
Total Dr. Not Met Met Once Total Coverage
Once Coverage Calls
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0 0 0 0.0 0.0 0
 Core Dr. Coverage
No. of
Call Chemist
No. of POB Name of ME : Days Met
Avg. Call Avg. Not Met Met Once
Chemist Worked Twice
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0 0.0 0 0 0 0 0
 Dec-12
Core Dr. Coverage Important Dr. Coverage

% Core % DML
Met > Met > % Coverage
Total Dr. Not Met Met Once Total
Twice Once Coverage
Coverage
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0.0 0 0.0 0.0
0 0 0.0 0 0 0 0 0.0 0.0
 Core Dr. Coverage
Total No. No. of
Call Chemist
of Dr. No. of POB Name of ME : Days
Avg. Call Avg. Not Met Met Once
Calls Chemist Worked
Met
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0.0 0.0
0 0.0 0 0.0 0.00 0 0 0
 Jan-13
Core Dr. Coverage Important Dr. Coverage

% Core
Met Met > Met > %
Total Dr. Not Met Met Once Total
Twice Twice Once Coverage
Coverage
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0.0 0 0.0
0 0 0 0.0 0 0 0 0 0.0

106 162
 Core Dr.
Total No. No. of
% DML Call Chemist
of Dr. No. of POB Name of ME : Days
Coverage Avg. Call Avg. Not Met
Calls Chemist Worked
Met
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0 0.0 0 0.0 0.00 0 0
 Feb-13
Core Dr. Coverage Important Dr. Coverage

% Core
Met Met > Met >
Met Once Total Dr. Not Met Met Once Total
Twice Twice Once
Coverage
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0.0 0
0 0 0 0 0.0 0 0 0 0
overage
Total No. No. of
% DML Call Chemist
% of Dr. No. of POB Name of ME : Days
Coverage Avg. Call Avg.
Coverage Calls Chemist Worked
Met
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0.0 0.0
0.0 0.0 0 0.0 0 0.0 0.00 0
 Mar-13
Core Dr. Coverage Important Dr. Coverage

% Core
Met Met > Met >
Not Met Met Once Total Dr. Not Met Met Once
Twice Twice Once
Coverage
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0.0
0 0 0 0 0 0.0 0 0 0
rtant Dr. Coverage
Total No.
% DML Call Chemist
% of Dr. No. of POB
Total Coverage Avg. Call Avg.
Coverage Calls Chemist
Met
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0.0 0.0
0 0.0 0.0 0 0.0 0 0.0 0.00
Wockhardt - Spectra

Name of RM :
HQ:

ROB Analysis
Aug-12
POWERCEF

H.Q No. of ROB Units on ROB Last Mth Sec Current Sec Impact
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
 FLOXUR OZ Count 2 susp as 1 strip

Aug-12
FLOXUR-OZ POWERCEF

Units on Last Mth Current Units on

No. of ROB ROB(Tab+Susp) Sec(Tab+Susp) Sec(Tab+Susp) Impact No. of ROB ROB
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
 Sep-12
POWERCEF FLOXUR-OZ POWERC
Units on Last Mth Current
Last Mth Current ROB(Tab Sec(Tab+ Sec(Tab+
Sec Sec Impact No. of ROB +Susp) Susp) Susp) Impact No. of ROB
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
 Oct-12
POWERCEF FLOXUR-OZ
Units on Last Mth Current
Units on Last Mth Current ROB(Tab Sec(Tab+ Sec(Tab+
ROB Sec Sec Impact No. of ROB +Susp) Susp) Susp) Impact
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
#DIV/0! #DIV/0!
Wockhardt - Spectra

Name of RM :
HQ:

CEFIWOK O/XL/PMS TR

Doctor's Name TM's Name H.Q MOB/PH. NO.

SL.NO.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
CEFIWOK O/XL/PMS TRIAL DOCTOR LIST

Jun-12 Jul-12 Aug-12

Potential/ Month Visit Date Current Visit Date Current Visit Date Current
TM/RM/ZSM Support TM/RM/ZSM Support TM/RM/ZSM Support
 Sep-12
Visit Date CurrentS
TM/RM/ZSM upport